Self-reports of executive dysfunction in current ecstasy/polydrug users

Cognitive and Behavioral Neurology

Volumn 25, Issue 3, 2012, Pages 128-138

  Hadjiefthyvoulou, Florentia ^a   Fisk, John E ^b   Montgomery, Catharine ^c   Bridges, Nikola ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

BRIEF A; cocaine; ecstasy; executive function; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE; ILLICIT DRUG; NICOTINE;

ADULT; ARTICLE; BEHAVIOR RATING INVENTORY OF EXECUTIVE FUNCTION ADULT VERSION; CIGARETTE SMOKING; CLINICAL ARTICLE; COGNITIVE DEFECT; COGNITIVE FAILURES QUESTIONNAIRE; CONTROLLED STUDY; EVERYDAY MEMORY QUESTIONNAIRE; FEMALE; HUMAN; LABORATORY TEST; MALE; PLANNING; PRIORITY JOURNAL; PROSPECTIVE AND RETROSPECTIVE MEMORY QUESTIONNAIRE; QUESTIONNAIRE; RATING SCALE; SELF MONITORING; SELF REPORT; TASK PERFORMANCE; WORKING MEMORY;

ADOLESCENT; ADULT; COGNITION DISORDERS; DIAGNOSTIC SELF EVALUATION; DRUG USERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; SELF REPORT; SUBSTANCE-RELATED DISORDERS;

EID: 84866400878     PISSN: 15433633     EISSN: 15370887     Source Type: Journal    
DOI: 10.1097/WNN.0b013e318261459c     Document Type: Article

References (61)

1. Friedman NP, Miyake A, Young SE, et al. Individual differences in executive functions are almost entirely genetic in origin. J Exp Psychol Gen. 2008;137:201-225.
2. Collette F, Van der Linden M, Laureys S. Exploring the unity and diversity of the neural substrates of executive functioning. Hum Brain Mapp. 2005;25:409-423.
3. Smith EE, Jonides J. Storage and executive processes in the frontal lobes. Science. 1999;283:1657-1661.
4. Green AR, Mechan AO, Elliott JM, et al. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55:463-508.
5. Morgan MJ. Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berl). 2000;152: 230-248.
6. Murphy PN, Wareing M, Fisk JE, et al. Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review. Neuropsychobiology. 2009;60:159-175.
7. Roth RM, Isquith PK, Gioia GA. Behavior Rating Inventory of Executive Function-Adult Version. Odessa, FL: Psychological Assessment Resources Inc.; 2005.
8. Bodnar LE, Prahme MC, Cutting LE, et al. Construct validity of parent ratings of inhibitory control. Child Neuropsychol. 2007;13: 345-362.
9. Chang W, Davies PL, Gavin WJ. Error monitoring in college students with attention-deficit/hyperactivity disorder. J Psychophysiol. 2009;23:113-125.
10. Gioia GA, Isquith PK, Kenworthy L, et al. Profiles of everyday executive function in acquired and developmental disorders. Child Neuropsychol. 2002;8:121-137.
11. Jarratt KP, Riccio CA, Siekierski BM. Assessment of attention deficit hyperactivity disorder (ADHD) using the BASC and BRIEF. Appl Neuropsychol. 2005;12:83-93.
12. Mahone EM, Hoffman J. Behavior rating of executive function among preschoolers with ADHD. Clin Neuropsychol. 2007;21:569-586.
13. Toplak ME, Bucciarelli MS, Jain U, et al. Executive functions: performance-based measures and the Behavior Rating Inventory of Executive Function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol. 2009;15:53-72.
14. Shear PK, DelBello MP, Rosenberg HL, et al. Parental reports of executive dysfunction in adolescents with bipolar disorder. Child Neuropsychol. 2002;8:285-295.
15. Gilotty L, Kenworthy L, Sirian L, et al. Adaptive skills and executive function in autism spectrum disorders. Child Neuropsychol. 2002;8:241-248.
16. Chan AS, Cheung MH, Yvonne MY, et al. Executive function deficits and neural discordance in children with autism spectrum disorders. Clin Neurophysiol. 2009;120:1107-1115.
17. Sherman EMS, Slick DJ, Eyrl KL. Executive dysfunction is a significant predictor of poor quality of life in children with epilepsy. Epilepsia. 2006;47:1936-1942.
18. Malloy P, Grace I. A review of rating scales for measuring behavior change due to frontal systems damage. Cogn Behav Neurol. 2005;18:18-27.
19. Gioia GA, Isquith PK. Ecological assessment of executive function in traumatic brain injury. Dev Neuropsychol. 2004;25:135-158.
20. Wareing M, Fisk JE, Murphy P, et al. Verbal working memory deficits in current and previous users of MDMA. Hum Psychopharm Clin. 2004;19:225-234.
21. Wareing M, Fisk JE, Murphy P, et al. Visuo-spatial working memory deficits in current and former users of MDMA ('Ecstasy'). Hum Psychopharm Clin. 2005;20:115-123.
22. Solowij N, Hall W, Lee N. Recreational MDMA use in Sydney: a profile of ecstasy users and their experiences with the drug. Br J Addiction. 1992;87:1161-1172.
23. Montgomery C, Fisk JE, Newcombe R, et al. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. Psychopharmacology (Berl). 2005;182:262-276.
24. Raven J, Raven JC, Court JH.Manual for Raven's ProgressiveMatrices and Vocabulary Scales. Oxford, UK: Psychologists Press; 1998.
25. Hadjiefthyvoulou F, Fisk JE, Montgomery C, et al. Everyday and prospective memory deficits in ecstasy/polydrug users. J Psychopharmacol. 2011;25:453-464.
26. Hadjiefthyvoulou F, Fisk JE, Montgomery C, et al. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT). Psychopharmacology (Berl). 2011;215:761-774.
27. Rabin LA, Roth RM, Isquith PK, et al. Self-and informant reports of executive function on the BRIEF-A in MCI and older adults with cognitive complaints. Arch Clin Neuropsych. 2006;21:721-732.
28. Slick DJ, Lautzenhiser A, Sherman EMS, et al. Frequency of scale elevations and factor structure of the Behavior Rating Inventory of Executive Function (BRIEF) in children and adolescents with intractable epilepsy. Child Neuropsychol. 2006;12:181-189.
29. Cornish IM. Factor structure of the Everyday Memory Questionnaire. Brit J Psychol. 2000;91:427-438.
30. Sunderland A, Harris JE, Baddeley AD. Do laboratory tests predict everyday memory? J Verb Learn Verb Beh. 1983;22:341-357.
31. Broadbent DE, Cooper PF, FitzGerald P, et al. The Cognitive Failure Questionnaire (CFQ) and its correlates. Brit J Clin Psychol. 1982;21:1-16.
32. Smith-Spark JH, Fawcett A, Nicolson RI, et al. Dyslexia and everyday cognitive performance. Memory. 2004;12:174-182.
33. Crawford JR, Smith G, Maylor EA, et al. The Prospective and Retrospective Memory Questionnaire (PRMQ): Normative data and latent structure in a large non-clinical sample. Memory. 2003;11:261-275.
34. Tabachnick BG, Fidell LS. Using Multivariate Statistics. 5th ed. Boston: Allyn and Bacon; 2007.
35. Righi S, Mecacci L, Viggiano MP. Anxiety, cognitive self-evaluation and performance: ERP correlates. J Anxiety Disord. 2009;23: 1132-1138.
36. Eschen A, Martin M, Gasser US, et al. Prospective and retrospective memory complaints in mild cognitive impairment and mild Alzheimer's disease. Brain Impair. 2009;10:59-75.
37. Bjnebekk A, Westlye LT, Walhovd KB, et al. Everyday memory: self-perception and structural brain correlates in a healthy elderly population. J Int Neuropsych Soc. 2010;16:1115-1126.
38. Miyake A, Friedman NP, Emerson MJ, et al. The unity and diversity of executive functions, and their contributions to complex "frontal lobe" tasks: a latent variable analysis. Cognit Psychol. 2000;41:49-100.
39. Morgan MJ. Recreational use of 'ecstasy' (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology. 1998;19:252-264.
40. Fox HC, Parrott AC, Turner JJD. Ecstasy use: cognitive deficits related to dosage rather than self-reported use of the drug. J Psychopharmacol. 2001;15:273-281.
41. Clark L, Roiser JP, Robbins TW, et al. Disrupted 'reflection' impulsivity in cannabis users but not current or former ecstasy users. J Psychopharmacol. 2009;23:14-22.
42. Schilt T, Goudriaan AE, Koeter MW, et al. Decision making as a predictor of first ecstasy use: a prospective study. Psychopharmacology (Berl). 2009;203:519-527.
43. Moeller FG, Dougherty DM, Steinberg JL, et al. Heavy 'ecstasy' use is associated with increased impulsivity. Addict Disord Their Treat. 2002;1:47-52.
44. Quednow BB, Ku hn K-U, Hoppe C, et al. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ('Ecstasy'). Psychopharmacology (Berl). 2007;189:517-530.
45. Morgan MJ, Impallomeni LC, Pirona A, Rogers RD. Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drug-nave controls. Neuropsychopharmacology. 2006;31:1562-1573.
46. Mah L, Arnold MC, Grafman J. Impairment of social perception associated with lesions of the prefrontal cortex. Am J Psychiatry. 2004;161:1247-1255.
47. Beer JS, John OP, Scabini D, et al. Orbitofrontal cortex and social behavior: integrating self-monitoring and emotion-cognition interactions. J Cogn Neurosci. 2006;18:871-879.
48. Ersche KD, Barnes A, Jones PS, et al. Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain. 2011;134: 2013-2024.
49. McCann UD, Szabo Z, Vranesic M, et al. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (?)3,4-methylenedioxymethamphetamine ("ecstasy") users: Relationship to cognitive performance. Psychopharmacology (Berl). 2008;200:439-450.
50. Reay JL, Hamilton C, Kennedy DO, et al. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. J Psychopharmacol. 2006;20:385-388.
51. Xu J, Mendrek A, Cohen MS, et al. Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence. Biol Psychiatry. 2005;58:143-150.
52. Xu J, Mendrek A, Cohen MS, et al. Effects of acute smoking on brain activity vary with abstinence in smokers performing the nback task: a preliminary study. Psychiatry Res. 2006;148:103-109.
53. Atzori G, Lemmonds CA, Kotler ML, et al. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal. J Clin Psychopharmacol. 2008;28:667-674.
54. Jacobsen LK, Krystal JH, Mencl WE, et al. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry. 2005;57:56-66.
55. Jacobsen LK, Mencl WE, Constable RT, et al. Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology (Berl). 2007;193:557-566.
56. Caspers K, Arndt S, Yucuis R, et al. Effects of alcohol-and cigarette-use disorders on global and specific measures of cognition in middle-age adults. J Stud Alcohol Drugs. 2010;71:192-200.
57. Razani J, Boone K, Lesser I, et al. Effects of cigarette smoking history on cognitive functioning in healthy older adults. Am J Geriatr Psychiatry. 2004;12:404-411.
58. Schinka JA, Vanderploeg RD, Rogish M, et al. Effects of the use of alcohol and cigarettes on cognition in elderly adults. J Int Neuropsychol Soc. 2002;8:811-818.
59. Glass JM, Buu A, Adams KM, et al. Effects of alcoholism severity and smoking on executive neurocognitive function. Addiction. 2009;104:38-48.
60. Fisk JE, Montgomery C. Sleep impairment in ecstasy/polydrug and cannabis-only users. Am J Addict. 2009;18:430-437.
61. Montgomery C, Fisk JE. Everyday memory deficits in ecstasypolydrug users. J Psychopharmacol. 2007;21:709-717.